Monday, March 12, 2012

Buprenorphine and Naloxone for Treatment of Opioid Dependence


Buprenorphine and Naloxone for Treatment of Opioid Dependence [CME Program]
by
Thomas Rowell, MD
Behavioral Health, Affinity Medical Group

Originally Presented on :
Wednesday, February 22, 2012 – 12:00 noon – Mercy Medical Center

OBJECTIVES
Following this CME activity, participants to will be able to:
1. Identify the indications for use of Buprenorphine/Naloxone.
2. Undersatnd the mechanisms of action of Buprenorphine/Naloxone.
3. Understand the efficacy,side effects, risk and benefits of Buprenorphine/Naloxone.


TARGET AUDIENCE
Primary care physicians and other interested specialists and allied health professionals.

CREDIT DESIGNATION
This program is presented for informational purposes only. As of November 22, 2011, Affinity Health System no longer offers CME credit for enduring materials.

Link to the PowerPoint with Audio as a full screen
          System Requirements


Link to the Audio Only


Presentation Handout (Affinity access only)
Please be patient. This is a large file that may take a moment to download.

Buprenorphine & Naloxone for Opioid Dependence

Buprenorphine and Naloxone for Treatment of Opioid Dependence
by
Thomas Rowell, MD
Behavioral Health, Affinity Medical Group

Originally Presented
Wednesday, February 22, 2012 – 12:00 noon – Mercy Medical Center